ZyVersa Therapeutics, Inc. Quarterly Return On Assets in % from Q4 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
ZyVersa Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q4 2022 to Q2 2024.
  • ZyVersa Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -90.9 %, a 5.38% increase year-over-year.
  • ZyVersa Therapeutics, Inc. annual Return On Assets for 2023 was -195 %, a 1137% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -90.9 +5.17 +5.38% Jun 30, 2024
Q1 2024 -359 -355 -7409% Mar 31, 2024
Q4 2023 -195 -194 -37101% Dec 31, 2023
Q3 2023 -114 Sep 30, 2023
Q2 2023 -96.1 Jun 30, 2023
Q1 2023 -4.79 Mar 31, 2023
Q4 2022 -0.52 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.